Why American Healthcare REIT is back on investors’ radar

American Healthcare REIT (AHR) has drawn fresh attention after reporting second quarter results with higher revenue and net income than a year earlier, alongside raised full year earnings guidance for 2026.

At a share price of $54.42, American Healthcare REIT has delivered a year to date share price return of 15.2% and a 1 year total shareholder return of 36.04%. This suggests momentum has built over the year even with a 1 month share price pullback of 4.79% and a modest 1 day dip of 0.48% following its earnings beat, raised 2026 guidance and the recent $712.2m follow on equity offering priced close to the current level.

If this kind of renewed interest in American Healthcare REIT has you thinking about where else capital might be heading in healthcare, it could be a good time to scan for other opportunities in 42 healthcare AI stocks

After a strong run and a fresh equity raise near today’s price, the question around American Healthcare REIT now is simple. Is most of the easy upside already behind the stock, or is there still meaningful value on the table?

Most Popular Narrative: 11.6% Undervalued

On the most followed narrative, American Healthcare REIT's fair value of $61.53 sits above the recent $54.42 share price, which frames the current debate around upside potential.

The company's disciplined portfolio optimization selling older, lower-quality assets and redeploying proceeds into modern, higher-acuity, and recently developed properties at below replacement cost should improve asset quality and accelerate future AFFO and earnings growth as new assets stabilize.

Want to see what is baked into that premium fair value for American Healthcare REIT? The narrative leans on sustained revenue expansion, rising margins and a future earnings base that looks very different to today.

Result: Fair Value of $61.53 (UNDERVALUED)

However, there are clear pressure points that could challenge the American Healthcare REIT story, including slower occupancy gains in senior housing and reimbursement changes that weigh on margins.

Another View: What American Healthcare REIT’s P/E Is Telling You

The popular fair value narrative paints American Healthcare REIT as undervalued, yet the current P/E of 104x is very high compared with the Global Health Care REITs average of 17.2x, the peer average of 45.1x and a fair ratio of 51.8x that the market could move towards. That gap points to meaningful valuation risk if expectations reset, so the key question is whether you think American Healthcare REIT’s growth story fully justifies paying this much more than the sector.

Next Steps

With both optimism around American Healthcare REIT's potential and concerns about its risks in focus, it makes sense to review the details for yourself. To weigh both sides with a clear view of what investors are watching, take a close look at the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond American Healthcare REIT?

If you want to keep sharpening your edge after looking at American Healthcare REIT, use the Simply Wall St screener to uncover fresh opportunities that fit your style.

• Target potential mispricings by scanning for quality companies that still look overlooked using the 50 high quality undervalued stocks.
• Prioritise reliability by focusing on businesses that pair income with resilience through the 11 dividend fortresses.
• Stay on the front foot by sourcing fresh prospects with strong fundamentals that many investors have not yet focused on via the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.